BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31776318)

  • 21. A Case of the nephrotic syndrome in bone marrow transplantation recipient, histologically showing overlapped glomerular lesions of thrombotic microangiopathy and membranous nephropathy.
    Masuzawa N; Nishimura A; Kitani T; Tamagaki K; Sugitani M; Nagoshi H; Kuroda J; Konishi E
    Pathol Int; 2017 Dec; 67(12):620-625. PubMed ID: 28940837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short Course of Eculizumab May Be Effective in Dialysis-Dependent Transplantation-Associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation: A Case Report.
    Jarmoliński T; Rosa M; Puziewicz-Zmonarska A; Kałwak K
    Transplant Proc; 2020 Oct; 52(8):2544-2547. PubMed ID: 32917392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
    Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
    Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.
    Gavriilaki E; Sakellari I; Karafoulidou I; Pasteli N; Batsis I; Mallouri D; Lazaridou A; Iskas M; Vardi A; Papalexandri A; Tsompanakou A; Papaemmanouil S; Ilias A; Anagnostopoulos A
    Int J Hematol; 2019 Nov; 110(5):529-532. PubMed ID: 31586304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and outcomes of pediatric transplant-associated thrombotic microangiopathy in Hong Kong.
    Chan WYK; Ma ALT; Chan EYH; Kan ANC; Ng WF; Lee PPW; Cheuk DKL; Chiang AKS; Leung W; Chan GCF
    Pediatr Transplant; 2022 Nov; 26(7):e14366. PubMed ID: 35860972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT.
    Elfeky R; Lucchini G; Lum SH; Ottaviano G; Builes N; Nademi Z; Battersby A; Flood T; Owens S; Cant AJ; Young H; Greener S; Walsh P; Kavanagh D; Annavarapu S; Rao K; Amrolia P; Chiesa R; Worth A; Booth C; Skinner R; Doncheva B; Standing J; Gennery AR; Qasim W; Slatter M; Veys P
    Blood Adv; 2020 Jun; 4(11):2418-2429. PubMed ID: 32492158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD.
    Furukawa M; Wang X; Ohkawara H; Fukatsu M; Alkebsi L; Takahashi H; Harada-Shirado K; Shichishima-Nakamura A; Kimura S; Ogawa K; Ikezoe T
    Blood Adv; 2019 Jul; 3(14):2128-2143. PubMed ID: 31300420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
    Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Eculizumab in Thrombotic Microangiopathy Associated with Hematopoietic Stem Cell Transplantation.
    Demircioglu S; Dogan A; Demir C
    J Coll Physicians Surg Pak; 2021 Nov; 31(11):1359-1361. PubMed ID: 34689499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
    Cutler C; Henry NL; Magee C; Li S; Kim HT; Alyea E; Ho V; Lee SJ; Soiffer R; Antin JH
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):551-7. PubMed ID: 15983555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
    Gavriilaki E; Bousiou Z; Batsis I; Vardi A; Mallouri D; Koravou EE; Konstantinidou G; Spyridis N; Karavalakis G; Noli F; Patriarcheas V; Masmanidou M; Touloumenidou T; Papalexandri A; Poziopoulos C; Yannaki E; Sakellari I; Politou M; Papassotiriou I
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in critical care of the pediatric hematopoietic stem cell transplant patient.
    Chima RS; Abulebda K; Jodele S
    Pediatr Clin North Am; 2013 Jun; 60(3):689-707. PubMed ID: 23639663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Laskin BL; Goebel J; Davies SM; Jodele S
    Blood; 2011 Aug; 118(6):1452-62. PubMed ID: 21596850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-Disease.
    Gavriilaki E; Sakellari I; Chatzikonstantinou T; Bousiou Z; Mallouri D; Masmanidou M; Vardi A; Koravou EE; Kika F; Touloumenidou T; Papalexandri A; Yannaki E; Batsis I; Anagnostopoulos A
    Transplant Proc; 2021 Sep; 53(7):2261-2266. PubMed ID: 34417030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombotic Microangiopathy Increases the Risk of Chronic Kidney Disease but Not Overall Mortality in Long-term Transplant Survivors.
    Li A; Gupta R; Amos CI; Davis C; Pao E; Lee SJ; Hingorani SR
    Transplant Cell Ther; 2021 Oct; 27(10):864.e1-864.e5. PubMed ID: 34217847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombotic microangiopathy in transplantation and malignancy.
    Qu L; Kiss JE
    Semin Thromb Hemost; 2005 Dec; 31(6):691-9. PubMed ID: 16388420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation.
    Glezerman IG; Jhaveri KD; Watson TH; Edwards AM; Papadopoulos EB; Young JW; Flombaum CD; Jakubowski AA
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):976-84. PubMed ID: 20153836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.
    Jodele S; Fukuda T; Mizuno K; Vinks AA; Laskin BL; Goebel J; Dixon BP; Chima RS; Hirsch R; Teusink A; Lazear D; Lane A; Myers KC; Dandoy CE; Davies SM
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):307-315. PubMed ID: 26456258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney complications of hematopoietic stem cell transplantation.
    Singh N; McNeely J; Parikh S; Bhinder A; Rovin BH; Shidham G
    Am J Kidney Dis; 2013 May; 61(5):809-21. PubMed ID: 23291149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?
    Dhakal P; Bhatt VR
    Bone Marrow Transplant; 2017 Mar; 52(3):352-356. PubMed ID: 27775697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.